{"id":370,"date":"2014-10-23T11:59:16","date_gmt":"2014-10-23T15:59:16","guid":{"rendered":"http:\/\/www.gqr-lmc-nmp.ca\/?page_id=370"},"modified":"2023-03-31T15:03:15","modified_gmt":"2023-03-31T19:03:15","slug":"guidelines","status":"publish","type":"page","link":"https:\/\/www.gqr-lmc-nmp.ca\/system\/myeloproliferative-neoplasms-mpn\/guidelines\/?lang=en","title":{"rendered":"Treatment guidelines"},"content":{"rendered":"

Myeloproliferative Neoplasms treatment guidelines<\/b><\/h2>\n

Version 2018<\/strong><\/p>\n

\n

MPN treatment guidelines – Version 2018<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Myeloproliferative Neoplasms treatment guidelines Version 2018 MPN treatment guidelines – Version 2018<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":368,"menu_order":10,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/www.gqr-lmc-nmp.ca\/system\/wp-json\/wp\/v2\/pages\/370"}],"collection":[{"href":"https:\/\/www.gqr-lmc-nmp.ca\/system\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.gqr-lmc-nmp.ca\/system\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.gqr-lmc-nmp.ca\/system\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gqr-lmc-nmp.ca\/system\/wp-json\/wp\/v2\/comments?post=370"}],"version-history":[{"count":8,"href":"https:\/\/www.gqr-lmc-nmp.ca\/system\/wp-json\/wp\/v2\/pages\/370\/revisions"}],"predecessor-version":[{"id":829,"href":"https:\/\/www.gqr-lmc-nmp.ca\/system\/wp-json\/wp\/v2\/pages\/370\/revisions\/829"}],"up":[{"embeddable":true,"href":"https:\/\/www.gqr-lmc-nmp.ca\/system\/wp-json\/wp\/v2\/pages\/368"}],"wp:attachment":[{"href":"https:\/\/www.gqr-lmc-nmp.ca\/system\/wp-json\/wp\/v2\/media?parent=370"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}